Parnate Tablet, Film Coated
Product Images NDC 59212-447

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Parnate (NDC 59212-447). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanz Pharma (us) Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Parnate-label (Parnate Label)

Parnate-label (Parnate Label)
PARNATE 10 mg film-coated tablets label shows the product name and active ingredient tranylcypromine sulfate. The label indicates a package quantity of 100 tablets with oral administration. It includes storage instructions, a federal dispensing warning, and details that the tablets are manufactured by Concordia Pharmaceuticals and distributed by Advipharm Limited. The label also features the product NDC 59212-447-10, barcode, and legal and manufacturing information.*
FDA Label Image

Structural Formula (Structural Formula)

Structural Formula (Structural Formula)
Chemical structure of tranylcypromine sulfate, showing the molecular arrangement including an amine group, cyclopropyl ring, and phenyl ring with sulfate (H2SO4) elements.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.